rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Cadre Holdings, Inc.

CDRE · NYSE

Health CareMedical DevicesSetting upDefense-Tech

CDRE stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 0.8% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 33
Industry in uptrend
29% -2 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$104.5M
Officials’ trades on record
7
Institutions holding
147 (-8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$51.7M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

7 disclosed lines: House 7, Senate 0, executive 0; 2 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k30 Jun 2026filed 2 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k16 Mar 2026filed 7 Apr 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k11 Jun 2025filed 10 Jul 2025
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k17 Apr 2025filed 14 May 2025
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k27 Jan 2025filed 10 Feb 2025
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k27 Dec 2024filed 14 Jan 2025
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k6 Dec 2024filed 14 Jan 2025

Insiders

Buy orders, 12 months0
Sale orders, 12 months15
Buyers · sellers0 · 3
WhoDidSharesTraded
Warren B. KandersCEO AND CHAIRMANsold55,345at $31.5425 Aug 2026filed 26 Aug 2026
Warren B. KandersCEO AND CHAIRMANsold44,655at $32.2825 Aug 2026filed 26 Aug 2026
Warren B. KandersCEO AND CHAIRMANsold65,431at $33.2024 Aug 2026filed 26 Aug 2026
Warren B. KandersCEO AND CHAIRMANsold34,569at $33.6524 Aug 2026filed 26 Aug 2026
Brad WilliamsPRESIDENTsold104at $34.3417 Aug 2026filed 19 Aug 2026
Brad WilliamsPRESIDENTsold88,638at $33.2417 Aug 2026filed 19 Aug 2026
Warren B. KandersCEO AND CHAIRMANsold50,000at $27.4322 Jun 2026filed 23 Jun 2026
Warren B. KandersCEO AND CHAIRMANsold25,000at $27.8618 Jun 2026filed 23 Jun 2026
Warren B. KandersCEO AND CHAIRMANsold25,000at $28.6817 Jun 2026filed 17 Jun 2026
Warren B. KandersCEO AND CHAIRMANsold100,000at $28.1916 Jun 2026filed 17 Jun 2026
Warren B. KandersCEO AND CHAIRMANsold100,000at $30.0315 Jun 2026filed 17 Jun 2026
Warren B. KandersCEO AND CHAIRMANsold100,000at $31.9323 Mar 2026filed 24 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders147-8 on the quarter
New · exited20 · 28
Reported value$905.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20262,936,878$83.7M+310,495+11.8%
Greenhouse Funds LLLPadded · filed 14 Aug 20262,868,664$81.8M+2860.0%
REINHART PARTNERS, LLC.added · filed 8 Jul 20262,738,373$78.1M+500,476+22.4%
FMR LLCreduced · filed 13 Aug 20262,475,623$70.6M-843,573−25.4%
STATE STREET CORPadded · filed 7 Aug 20261,949,734$55.6M+553,411+39.6%
Capital International Investorsadded · filed 12 Aug 20261,622,466$46.3M+361,660+28.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,324,254$37.8M+76,805+6.2%
Capital World Investorsadded · filed 12 Aug 20261,205,237$34.4M+32,880+2.8%
WYNNEFIELD CAPITAL INCadded · filed 14 Aug 20261,205,000$34.4M+55,000+4.8%
Select Equity Group, L.P.added · filed 14 Aug 20261,181,921$33.7M+433,423+57.9%
31 Mar 2023 – 30 Jun 2026
63108152Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Warren B. Kanders Company insiderCEO AND CHAIRMAN · last 25 Aug 20260 · 66
Brad Williams Company insiderPRESIDENT · last 17 Aug 20261 · 13
Gilbert Ray Cisneros, Jr. HouseCA31 · last 30 Jun 20263 · 0
Blaine Browers Company insiderCHIEF FINANCIAL OFFICER · last 16 Jun 20261 · 5
Hamish Norton Company insiderDirector · last 16 Jun 20260 · 0
Mary E. Kissel Company insiderDirector · last 16 Jun 20260 · 0
Nicolas Sokolow Company insiderDirector · last 16 Jun 20260 · 29
William G. Quigley III Company insiderDirector · last 16 Jun 20260 · 0
Deborah A. Decotis Company insiderDirector · last 30 May 20250 · 0
Gianmaria C. Delzanno Company insiderDirector · last 30 May 20250 · 0
Josh Gottheimer HouseNJ05 · last 17 Apr 20252 · 2

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+57%
ATRC AtriCureLeading+54%
HAE HaemoneticsLeading+43%
BVS BioventusLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202542.5%
Operating profit marginFY 2025 · to 31 Dec 202511.0%
Free cash flow marginFY 2025 · to 31 Dec 20259.3%
Return on capital employedFY 2025 · to 31 Dec 202510.1%
Cash conversionFY 2025 · to 31 Dec 2025144%
Debt to equityFY 2025 · to 31 Dec 20250.97×
Research spendFY 2025 · to 31 Dec 20251.9%
Dividend growthFY 2025 · to 31 Dec 20250.0%
Share count trendFY 2025 · to 6 Mar 20261.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$122.9M
Free cash flowFY 2025 · to 31 Dec 2025$56.8M

Analyst forecasts

No analyst forecasts yet.